Beyond Glucose Monitoring: Multianalyte Sensor Use in Diabetes.

Kathy Zhou,Steven James,Michele Gaca,Ashani Lecamwasam,Muamer Dervisevic,David N O'Neal,Nicolas Voelcker,Elif Ilhan Ekinci

DOI: https://doi.org/10.1089/dia.2024.0250

2024-07-27

Diabetes Technology & Therapeutics

Abstract:Diabetes Technology &Therapeutics, Volume 0, Issue ja, -Not available-.

endocrinology & metabolism

What problem does this paper attempt to address?

Multi-parameter Biosensor for Diabetes Monitoring

YQ Chen,WJ Guan,G Li,M Pan

DOI: https://doi.org/10.3321/j.issn:0253-3820.2004.09.019

2004-01-01

Abstract:Anovel multi-parameter biosensor, which can measure blood glucose, lactic acid, cholesterol and beta-hydrobutyric acid simultaneously, is designed for monitoring diabetes. It combines the techniques of enzymatic analytical chemistry and micro electronic mechanical systems (MEMS). On a polymeric substrate, carbon electrode is screen-printed and an enzyme sensing film is coated. In order to obtain a good stability, some amylose are added into the enzyme film. The sensing ranges of the sensor for blood glucose(Glu), Total cholesterol (T-ch), lactic acid (LAC) and beta- hydrobutyric acid (HBA) are 1 similar to 30 mmol/L, 1.0 similar to 4.0 g/L, 1 similar to 15 mmol/L and 20 similar to 700 g/L, respectively while the corresponding response times are 20, 180, 50 and 50 seconds, respectively. Experimental results show that the correlation coefficient between the sensor and regular biochemical analyzer for hospital is greater than 0.92.
Glucose sensors: a review of current and emerging technology

N. S. Oliver,C. Toumazou,A. E. G. Cass,D. G. Johnston

DOI: https://doi.org/10.1111/j.1464-5491.2008.02642.x

IF: 3.5

2009-03-01

Diabetic Medicine

Abstract:Glucose monitoring technology has been used in the management of diabetes for three decades. Traditional devices use enzymatic methods to measure glucose concentration and provide point sample information. More recently continuous glucose monitoring devices have become available providing more detailed data on glucose excursions. In future applications the continuous glucose sensor may become a critical component of the closed loop insulin delivery system and, as such, must be selective, rapid, predictable and acceptable for continuous patient use. Many potential sensing modalities are being pursued including optical and transdermal techniques. This review aims to summarize existing technology, the methods for assessing glucose sensing devices and provide an overview of emergent sensing modalities.

endocrinology & metabolism
Monitoring Technologies – Continuous Glucose Monitoring, Mobile Technology, Biomarkers of Glycemic Control

K. Dungan

2014-04-30

Abstract:It is recognized that traditional measures of glucose control (such as hemoglobin A1c [A1C]) provide little information regarding the need for day to day changes in therapies. While intermittent self-monitored blood glucose (SMBG) provides additional information with which to make treatment decisions, significant barriers to its use exist, such as inconvenience and lack of timely and regular feedback. Furthermore, important information regarding glucose trends may be missed. Continuous glucose monitoring (CGM) has become increasingly reliable and has demonstrated efficacy in terms of improving A1C, reducing hypoglycemia, and improving the time in target glucose range. Incremental progress continues to be made toward a fully functional artificial pancreas, of which CGM will play a vital role. As more and more data are presented to patients and providers, it has become increasingly paramount that the data are organized in a standardized way and that communication of data is streamlined using patients’ mobile devices where available and within the existing clinic infrastructure. Systems that provide immediate feedback to patients and decision support tools for patients and providers have demonstrated superior outcomes compared to routine SMBG alone. Alternate markers of glucose control may provide complementary information about glucose control and long-term prognosis. This chapter will review the latest evidence for use of professional and personal CGM, mobile glucose monitoring approaches, and biomarkers of glycemic control. For complete coverage of all related areas of Endocrinology, please visit our on-line FREE web-text, WWW.ENDOTEXT.ORG .

Medicine
Mitigating Severe Hypoglycemia in Users of Advanced Diabetes Technologies: Impaired Awareness of Hypoglycemia and Unhelpful Hypoglycemia Beliefs as Targets for Interventions

Yu Kuei Lin,Wen Ye,Helen Rogers,Augustin Brooks,Elena Toschi,Dulmini Kariyawasam,Simon Heller,Nicole de Zoysa,Stephanie Amiel

DOI: https://doi.org/10.1089/dia.2024.0039

2024-04-26

Diabetes Technology & Therapeutics

Abstract:Diabetes Technology &Therapeutics, Volume 0, Issue ja, -Not available-.

endocrinology & metabolism
Advancements of Glucose Monitoring Biosensor: Current State, Generations of Technological Progress, and Innovation Dynamics

Arpita Dua,Abhijit Debnath,Kunal Kumar,Rupa Mazumder,Avijit Mazumder,Rajesh Singh,Saloni Mangal,Jahanvi Sanchitra,Fahad Khan,Soumya Tripathi,Sukriti Vishwas,Hema Chaudhary,Parul Sharma,Shikha Srivastava

DOI: https://doi.org/10.2174/0113892010305386240625072535

2024-07-12

Abstract:Glucose monitoring is essential for managing diabetes, and continuous glucose monitoring biosensors can offer real-time monitoring with little invasiveness. However, challenges remain in improving sensor accuracy, selectivity, and overall performance. This article aims to review current trends and recent advancements in glucose-monitoring biosensors while evaluating their benefits and limitations for diabetes monitoring. An analysis of current literature on transdermal glucose sensors was conducted, focusing on detection techniques, novel nanomaterials, and integrated sensor systems. Recent research has led to advancements in electrochemical, optical, electromagnetic, and sonochemical sensors for transdermal glucose detection. The use of novel nanomaterials and integrated sensor designs has improved sensitivity, selectivity, and accuracy. However, issues like calibration requirements, motion artifacts, and skin irritation persist. Transdermal glucose sensors show promise for non-invasive, convenient diabetes monitoring but require further enhancements to address limitations in accuracy, reliability, and biocompatibility. Continued research and innovation focusing on sensor materials, designs, and surface chemistry is needed to optimize biosensor performance and utility. The study offers a comprehensive analysis of the present status of technological advancement and highlights areas that need more research.
Commercial and Scientific Solutions for Blood Glucose Monitoring—A Review

Yirui Xue,Angelika S Thalmayer,Samuel Zeising,Georg Fischer,Maximilian Lübke,Angelika S. Thalmayer

DOI: https://doi.org/10.3390/s22020425

IF: 3.9

2022-01-06

Sensors

Abstract:Diabetes is a chronic and, according to the state of the art, an incurable disease. Therefore, to treat diabetes, regular blood glucose monitoring is crucial since it is mandatory to mitigate the risk and incidence of hyperglycemia and hypoglycemia. Nowadays, it is common to use blood glucose meters or continuous glucose monitoring via stinging the skin, which is classified as invasive monitoring. In recent decades, non-invasive monitoring has been regarded as a dominant research field. In this paper, electrochemical and electromagnetic non-invasive blood glucose monitoring approaches will be discussed. Thereby, scientific sensor systems are compared to commercial devices by validating the sensor principle and investigating their performance utilizing the Clarke error grid. Additionally, the opportunities to enhance the overall accuracy and stability of non-invasive glucose sensing and even predict blood glucose development to avoid hyperglycemia and hypoglycemia using post-processing and sensor fusion are presented. Overall, the scientific approaches show a comparable accuracy in the Clarke error grid to that of the commercial ones. However, they are in different stages of development and, therefore, need improvement regarding parameter optimization, temperature dependency, or testing with blood under real conditions. Moreover, the size of scientific sensing solutions must be further reduced for a wearable monitoring system.

engineering, electrical & electronic,chemistry, analytical,instruments & instrumentation
Challenges and perspectives in continuous glucose monitoring

Benjamin Jasha van Enter,Elizabeth von Hauff

DOI: https://doi.org/10.1039/c8cc01678j

2018-05-15

Abstract:Diabetes is a global epidemic that threatens the health and well-being of hundreds of millions of people. The first step in patient treatment is to monitor glucose levels. Currently this is most commonly done using enzymatic strips. This approach suffers from several limitations, namely it requires a blood sample and is therefore invasive, the quality and the stability of the enzymatic strips vary widely, and the patient is burdened by performing the measurement themselves. This results in dangerous fluctuations in glucose levels often going undetected. There is currently intense research towards new approaches in glucose detection that would enable non-invasive continuous glucose monitoring (CGM). In this review, we explore the state-of-the-art in glucose detection technologies. In particular, we focus on the physical mechanisms behind different approaches, and how these influence and determine the accuracy and reliability of glucose detection. We begin by reviewing the basic physical and chemical properties of the glucose molecule. Although these play a central role in detection, especially the anomeric ratio, they are surprisingly often overlooked in the literature. We then review state-of-the art and emerging detection methods. Finally, we survey the current market for glucometers. Recent results show that past challenges in glucose detection are now being overcome, thereby enabling the development of smart wearable devices for non-invasive continuous glucose monitoring. These new directions in glucose detection have enormous potential to improve the quality of life of millions of diabetics, as well as offer insight into the development, treatment and even prevention of the disease.
Insight into continuous glucose monitoring: from medical basics to commercialized devices

Ayman Chmayssem,Małgorzata Nadolska,Emily Tubbs,Kamila Sadowska,Pankaj Vadgma,Isao Shitanda,Seiya Tsujimura,Youssef Lattach,Martin Peacock,Sophie Tingry,Stéphane Marinesco,Pascal Mailley,Sandrine Lablanche,Pierre Yves Benhamou,Abdelkader Zebda

DOI: https://doi.org/10.1007/s00604-023-05743-w

2023-04-07

Mikrochimica Acta

Abstract:According to the latest statistics, more than 537 million people around the world struggle with diabetes and its adverse consequences. As well as acute risks of hypo- or hyper- glycemia, long-term vascular complications may occur, including coronary heart disease or stroke, as well as diabetic nephropathy leading to end-stage disease, neuropathy or retinopathy. Therefore, there is an urgent need to improve diabetes management to reduce the risk of complications but also to improve patient's quality life. The impact of continuous glucose monitoring (CGM) is well recognized, in this regard. The current review aims at introducing the basic principles of glucose sensing, including electrochemical and optical detection, summarizing CGM technology, its requirements, advantages, and disadvantages. The role of CGM systems in the clinical diagnostics/personal testing, difficulties in their utilization, and recommendations are also discussed. In the end, challenges and prospects in future CGM systems are discussed and non-invasive, wearable glucose biosensors are introduced. Though the scope of this review is CGMs and provides information about medical issues and analytical principles, consideration of broader use will be critical in future if the right systems are to be selected for effective diabetes management.
Current development in non-invasive glucose monitoring

Carlos Eduardo Ferrante do Amaral,Benhard Wolf

DOI: https://doi.org/10.1016/j.medengphy.2007.06.003

2008-06-01

Abstract:Painless control of blood glycemic levels could improve life quality of diabetes patients, enabling a better regulation of hyper- and hypoglycaemia episodes and thereby avoiding physiological complications. Although research groups have been trying for decades to separate non-invasive glucose information from interference compounds, none of the available commercial devices offers enough precision to replace lancet approaches. Many reviews have already been published on this topic, but the great amount of information available and the fast development of technologies require a continuous update in the research status. Besides the description of current in-vivo methods and the analysis of devices available commercially, one also explains treatment algorithms useful for multivariate analysis.

engineering, biomedical
Electrochemistry in diabetes management

Adam Heller,Ben Feldman

DOI: https://doi.org/10.1021/ar9002015

2010-07-20

Abstract:Diabetes devastates lives and burdens society. Hypoglycemic (low glucose) episodes cause blackouts, and severe ones are life-threatening. Periods of hyperglycemia (high glucose) cause circulatory disease, stroke, amputations, blindness, kidney failure and nerve degeneration. In this Account, we describe the founding of TheraSense, now a major part of Abbott Diabetes Care, and the development of two products that have improved the lives of people with diabetes. The first, a virtually painless microcoulometer (300 nL volume), the FreeStyle blood glucose monitoring system, was approved by the FDA and became available in 2000. In 2009, this system was used in more than one billion blood assays. The second, the enzyme-wiring based, subcutaneously-implanted FreeStyle Navigator continuous glucose monitoring system, was approved by the FDA and became available in the United States in 2008. The strips of the FreeStyle blood glucose monitoring system comprise a printed parallel plate coulometer, with a 50 microm gap between two facing printed electrodes, a carbon electrode and a Ag/AgCl electrode. The volume of blood between the facing plates is accurately controlled. The glucose is electrooxidized through catalysis by a glucose dehydrogenase (GDH) and an Os(2+/3+) redox mediator, which is reduced by the glucose-reduced enzyme and is electrooxidized on the carbon electrode. Initially the system used pyrroloquinoline quinone (PQQ)-dependent GDH but now uses flavin adenine dinucleotide (FAD)-dependent GDH. Because the facing electrodes are separated by such a small distance, shuttling of electrons by the redox couple could interfere with the coulometric assay. However, the Os(2+/3+) redox mediator is selected to have a substantially negative formal potential, between 0.0 and -0.2 V, versus that of the facing Ag/AgCl electrode. This makes the flow of a shuttling current between the two electrodes virtually impossible because the oxidized Os(3+) complex cannot be appreciably reduced at the more positively poised Ag/AgCl electrode. The FreeStyle Navigator continuous glucose monitoring system uses a subcutaneously implanted miniature plastic sensor connected to a transmitter to measure glycemia amperometrically and sends the information to a PDA-like device every minute. The sensor consists of a narrow (0.6 mm wide) plastic substrate on which carbon-working, Ag/AgCl reference, and carbon counter electrodes are printed in a stacked geometry. The active wired enzyme sensing layer covers only about 0.1 mm(2) of the working electrode and is overlaid by a flux-limiting membrane. It resides at about 5 mm depth in the subcutaneous adipose tissue and monitors glucose concentrations over the range 20-500 mg/dL. Its core component, a miniature, disposable, amperometric glucose sensor, has an electrooxidation catalyst made from a crosslinked adduct of glucose oxidase (GOx) and a GOx wiring redox hydrogel containing a polymer-bound Os(2+/3+) complex. Because of the selectivity of the catalyst for glucose, very little current flows in the absence of glucose. That feature, either alone or in combination with other features of the sensor, facilitates the one-point calibration of the system. The sensor is implanted subcutaneously and replaced by the patient after 5 days use with minimal pain. The wearer does not feel its presence under the skin.
An Overview of Current and Emerging Biomaterials Technology for Continuous Glucose Monitoring (CGM) Devices -- Current state and future perspectives of the leading technologies

Umme Hafsa Momy

2023-10-17

Abstract:In the world today, diabetic complications are a major factor in the disease's high mortality rate. Diabetes mellitus has been a major source of concern for decades due to its global prevalence and the resulting rising costs to individuals, governments, and healthcare systems on both a social and economic level. The complex interplay between nutrition, exercise, stress, medicine, sickness, and hormonal changes makes controlling diabetes difficult. Even though there is currently no cure for diabetes, the condition may be managed with careful attention to blood glucose levels and the use of appropriate medications. Blood sugar levels should be monitored on a regular basis, which requires a glucometer and a fingertip and is becoming the standard in diabetes control technologies. For the convenience of diabetic patients, the use of a CGM device for monitoring glucose levels has become the preferred method. For diabetes therapy at the point of care, replacing finger-prick glucometers can be done anywhere they are currently on the market. As a result, it has sparked a lot of interest in a variety of glucose sensing mechanisms, particularly non-invasive or marginally glucose sensing mechanisms that focus on subcutaneously implantable electrochemical sugar sensors that work more reliably and last longer.

Medical Physics,Systems and Control
Glucose oxidase-based biosensor for glucose detection from biological fluids

Pankaj Mandpe,Bala Prabhakar,Hunny Gupta,Pravin Shende

DOI: https://doi.org/10.1108/sr-01-2019-0017

2020-06-25

Sensor Review

Abstract:Purpose The present study aims to summarize different non-invasive techniques for continuous glucose monitoring (CGM) in diabetic patients using glucose-oxidase biosensors. In diabetic patients, the self-monitoring of blood glucose (BG) levels through minimally invasive techniques provides a quick method of measuring their BG concentration, unlike conventional laboratory measurements. The drawbacks of minimally invasive techniques include physical pain, anxiety and reduced patient compliance. To overcome these limitations, researchers shifted their attention towards the development of a pain-free and non-invasive glucose monitoring system, which showed encouraging results. Design/methodology/approach This study reviews the development of minimally and non-invasive method for continuous glucose level monitoring in diabetic or hyperglycemic patients. Specifically, glucose monitoring using non-invasive techniques, such as spectroscopy-based methods, polarimetry, fluorescence, electromagnetic variations, transdermal extraction-based methods and using body fluids, has been discussed. The various strategies adopted for improving the overall specificity and performance of biosensors are discussed. Findings In conclusion, the technology of glucose oxidase-based biosensors for glucose level monitoring is becoming a strong competitor, probably because of high specificity and selectivity, low cost and increased patient compliance. Many industries currently working in this field include Google, Novartis and Microsoft, which demonstrates the significance and strong market potential of self-monitored glucose-oxidase-based biosensors in the near future. Originality/value This review paper summarizes comprehensive strategies for continuous glucose monitoring (CGM) in diabetic patients using non-invasive glucose-oxidase biosensors. Non-invasive techniques received significant research interest because of high sensitivity and better patient compliance, unlike invasive ones. Although the results from these innovative devices require frequent calibration against direct BG data, they might be a preferable candidate for future CGM. However, the challenges associated with designing accurate level sensors to biomonitor BG data easily and painlessly needs to be addressed.

instruments & instrumentation
Continuous glucose monitoring metrics and hemoglobin A1c relationship in patients with type 2 diabetes treated by hemodialysis

Rodolfo Galindo,Bobak Moazzami,Katherine R. Tuttle,Richard M Bergenstal,Limin Peng,Guillermo Umpierrez

DOI: https://doi.org/10.1089/dia.2024.0145

2024-05-29

Diabetes Technology & Therapeutics

Abstract:Diabetes Technology &Therapeutics, Volume 0, Issue ja, -Not available-.

endocrinology & metabolism
Everything You Wanted to Know About Noninvasive Glucose Measurement and Control

Prateek Jain,Amit M. Joshi,Saraju Mohanty

DOI: https://doi.org/10.48550/arXiv.2101.08996

IF: 4.506

2021-01-22

Medical Physics

Abstract:Diabetes is a chronicle disease where the body of a human is irregular to dissolve the blood glucose properly. The diabetes is due to lack of insulin in human body. The continuous monitoring of blood glucose is main important aspect for health care. Most of the successful glucose monitoring devices is based on methodology of pricking of blood. However, such kind of approach may not be advisable for frequent measurement. The paper presents the extensive review of glucose measurement techniques. The paper covers various non-invasive glucose methods and its control with smart healthcare technology. To fulfill the imperatives for non-invasive blood glucose monitoring system, there is a need to configure an accurate measurement device. Noninvasive glucose-level monitoring device for clinical test overcomes the problem of frequent pricking for blood samples. There is requirement to develop the Internet-Medical-Things (IoMT) integrated Healthcare Cyber-Physical System (H-CPS) based Smart Healthcare framework for glucose measurement with purpose of continuous health monitoring. The paper also covers selective consumer products along with selected state of art glucose measurement approaches. The paper has also listed several challenges and open problems for glucose measurement.
Data capture of transdermal glucose monitoring through computerized appliance-based virtual remote sensing and alert systems

Robert Jameson,Daniel Lorence,Jennifer Lin

DOI: https://doi.org/10.1007/s10916-011-9686-1

Abstract:Monitoring of blood glucose levels is important to persons with diabetes or pre-diabetic, abnormal glucose indications. Such individuals must determine when insulin is needed to reduce glucose levels in their bodies, or when additional glucose must be administered to raise levels. A conventional technique used by many diabetics to personally monitor their glucose level includes the periodic drawing of blood, the application of blood to a test strip, and determination of blood glucose level using calorimetric, electrochemical, or photometric detection. This technique does not permit continuous or automatic monitoring of levels in the body, but typically must be performed manually, and on a periodic basis. Unfortunately, checking consistency varies widely among individuals, where wide variation of high or low levels of glucose or other analytes may have detrimental effects. The ongoing capture of data through continuous and/or automatic in vivo monitoring of analyte levels, and its inclusion with a user-friendly computer interface, is now possible using a subcutaneous implanted sensor. Such devices are small and comfortable when used, allowing a wide range of life activities. In this technology review we propose one promising model using a combination of emerging, systems-based technologies in non-invasive analyte monitoring, as integrated within household-based health monitoring using home appliances.
Insertable Biomaterial-Based Multianalyte Barcode Sensor toward Continuous Monitoring of Glucose and Oxygen

Ridhi Pradhan,David Chimene,Brian S. Ko,Artem Goncharov,Aydogan Ozcan,Michael J. McShane

DOI: https://doi.org/10.1021/acssensors.4c01926

IF: 8.9

2024-11-05

ACS Sensors

Abstract:Chronic diseases, including diabetes, cardiovascular diseases, and microvascular complications, contribute significantly to global morbidity and mortality. Current monitoring tools such as glucometers and continuous glucose monitors only measure one analyte; multiplexing technologies offer a promising approach for monitoring multiple biomarkers, enabling the management of comorbidities and providing more comprehensive disease insights. In this work, we describe a miniaturized optical "barcode"...

chemistry, multidisciplinary, analytical,nanoscience & nanotechnology
Assessing Patterns of CGM use and Metrics of Glycemic Control in T1D and T2D Patients in the Veterans Healthcare System: Integrating CGM Device Data with EHR Data

Tomoki Okuno,Sharon Macwan,Donald Miller,Gregory Norman,Peter Reaven,Jin Zhou

DOI: https://doi.org/10.1089/dia.2024.0083

2024-05-21

Diabetes Technology & Therapeutics

Abstract:Diabetes Technology &Therapeutics, Volume 0, Issue ja, -Not available-.

endocrinology & metabolism
Trends in Nanomaterial-Based Non-Invasive Diabetes Sensing Technologies

Prashanth Makaram,Dawn Owens,Juan Aceros

DOI: https://doi.org/10.3390/diagnostics4020027

2014-04-21

Abstract:Blood glucose monitoring is considered the gold standard for diabetes diagnostics and self-monitoring. However, the underlying process is invasive and highly uncomfortable for patients. Furthermore, the process must be completed several times a day to successfully manage the disease, which greatly contributes to the massive need for non-invasive monitoring options. Human serums, such as saliva, sweat, breath, urine and tears, contain traces of glucose and are easily accessible. Therefore, they allow minimal to non-invasive glucose monitoring, making them attractive alternatives to blood measurements. Numerous developments regarding noninvasive glucose detection techniques have taken place over the years, but recently, they have gained recognition as viable alternatives, due to the advent of nanotechnology-based sensors. Such sensors are optimal for testing the amount of glucose in serums other than blood thanks to their enhanced sensitivity and selectivity ranges, in addition to their size and compatibility with electronic circuitry. These nanotechnology approaches are rapidly evolving, and new techniques are constantly emerging. Hence, this manuscript aims to review current and future nanomaterial-based technologies utilizing saliva, sweat, breath and tears as a diagnostic medium for diabetes monitoring.
Unveiling the Spectrum of Glucose Variability: A Novel Perspective on FreeStyle Libre Monitoring Data

Adrian H. Heald,Mike Stedman,John Warner-Levy,Lleyton Belston,Angela Paisley,Aleksandra Jotic,Nebojsa Lalic,Martin Gibson,Hellena H. Habte-Asres,Martin Whyte,Angus Forbes

DOI: https://doi.org/10.1007/s13300-024-01647-x

2024-10-25

Diabetes Therapy

Abstract:Since the introduction of insulin therapy, it has become apparent that type 1 diabetes (T1D) is accompanied by long-term microvascular and macrovascular complications. In the context of the many benefits of continuous glucose monitoring (CGM), there remain opportunities to study the large amount of data now available in order to maximise its potential in the endeavour to reduce the occurrence of diabetes tissue complications in the longer term

endocrinology & metabolism
Noninvasive Glucose Sensing In Vivo

Ho Man Colman Leung,Gregory P Forlenza,Temiloluwa O Prioleau,Xia Zhou

DOI: https://doi.org/10.3390/s23167057

2023-08-09

Abstract:Blood glucose monitoring is an essential aspect of disease management for individuals with diabetes. Unfortunately, traditional methods require collecting a blood sample and thus are invasive and inconvenient. Recent developments in minimally invasive continuous glucose monitors have provided a more convenient alternative for people with diabetes to track their glucose levels 24/7. Despite this progress, many challenges remain to establish a noninvasive monitoring technique that works accurately and reliably in the wild. This review encompasses the current advancements in noninvasive glucose sensing technology in vivo, delves into the common challenges faced by these systems, and offers an insightful outlook on existing and future solutions.

Beyond Glucose Monitoring: Multianalyte Sensor Use in Diabetes.

Multi-parameter Biosensor for Diabetes Monitoring

Glucose sensors: a review of current and emerging technology

Monitoring Technologies – Continuous Glucose Monitoring, Mobile Technology, Biomarkers of Glycemic Control

Mitigating Severe Hypoglycemia in Users of Advanced Diabetes Technologies: Impaired Awareness of Hypoglycemia and Unhelpful Hypoglycemia Beliefs as Targets for Interventions

Advancements of Glucose Monitoring Biosensor: Current State, Generations of Technological Progress, and Innovation Dynamics

Commercial and Scientific Solutions for Blood Glucose Monitoring—A Review

Challenges and perspectives in continuous glucose monitoring

Insight into continuous glucose monitoring: from medical basics to commercialized devices

Current development in non-invasive glucose monitoring

Electrochemistry in diabetes management

An Overview of Current and Emerging Biomaterials Technology for Continuous Glucose Monitoring (CGM) Devices -- Current state and future perspectives of the leading technologies

Glucose oxidase-based biosensor for glucose detection from biological fluids

Continuous glucose monitoring metrics and hemoglobin A1c relationship in patients with type 2 diabetes treated by hemodialysis

Everything You Wanted to Know About Noninvasive Glucose Measurement and Control

Data capture of transdermal glucose monitoring through computerized appliance-based virtual remote sensing and alert systems

Insertable Biomaterial-Based Multianalyte Barcode Sensor toward Continuous Monitoring of Glucose and Oxygen

Assessing Patterns of CGM use and Metrics of Glycemic Control in T1D and T2D Patients in the Veterans Healthcare System: Integrating CGM Device Data with EHR Data

Trends in Nanomaterial-Based Non-Invasive Diabetes Sensing Technologies

Unveiling the Spectrum of Glucose Variability: A Novel Perspective on FreeStyle Libre Monitoring Data

Noninvasive Glucose Sensing In Vivo